MYCN and neuroblastoma: By comprehensively assessing the expression of 19 genes in NB tumor samples and cell lines, it was discovered that the mRNA expression level of AKR1C1 was significantly elevated in both high-risk NB groups and SK-N-BE2 (MYCN amplification NB cell line).